Top Cancer Stocks in United States
Browse the largest United States companies in the world ranked by their Market Capitalization. Global Cancer Companies in United States market cap is $106.64B.
29 Jan 2025, 14:33 UTC
Companies: 160
🇺🇸1 |  | $69.91 | 0.10% | 15.63B | 12.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸2 |  | $33.82 | 1.02% | 10.76B | 41.57% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸3 |  | $58.11 | -1.39% | 10.51B | -20.94% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇺🇸4 |  | $44.39 | 1.05% | 7.27B | 56.41% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸5 |  | $32.80 | -3.33% | 5.98B | -44.84% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸6 |  | $90.46 | 0.14% | 5.48B | -0.09% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸7 |  | $82.65 | -1.43% | 4.73B | 14.11% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $77.58 | 1.03% | 4.03B | 42.19% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸9 |  | $31.57 | 1.71% | 3.83B | 18.55% | Outperform S&P500 YTD Benchamark | ⚕️💻 Healthtech | - |
🇺🇸10 |  | $16.44 | -4.14% | 2.87B | 1033.79% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸11 |  | $36.81 | -1.50% | 2.65B | 1.97% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸12 |  | $56.14 | -1.07% | 2.59B | 425.66% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸13 |  | $7.49 | 0.40% | 1.92B | -6.14% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸14 |  | $3.34 | 0.00% | 1.81B | 59.05% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸15 |  | $25.30 | -0.32% | 1.63B | -28.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸16 |  | $15.91 | -0.31% | 1.19B | -16.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸17 |  | $13.07 | -1.80% | 1.11B | -38.52% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸18 |  | $12.67 | -0.16% | 1.10B | -11.77% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸19 |  | $2.75 | 1.10% | 1.05B | 227.38% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸20 |  | $18.73 | 4.06% | 1.03B | -54.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸21 |  | $11.25 | 18.54% | 1.01B | 1047.86% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸22 |  | $23.15 | -1.20% | 954.06M | 66.79% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸23 |  | $19.57 | -2.05% | 949.22M | 88.72% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸24 |  | $3.25 | 3.50% | 911.86M | 712.50% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸25 |  | $12.50 | 1.30% | 738.24M | 47.75% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸26 |  | $8.86 | -0.89% | 658.05M | -38.77% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸27 |  | $2.82 | 5.62% | 614.60M | 88.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸28 |  | $14.66 | -0.41% | 604.07M | -37.05% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸29 |  | $4.23 | -2.53% | 539.16M | -60.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸30 |  | $12.27 | 3.37% | 524.92M | 21.73% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸31 |  | $1.96 | 0.51% | 471.63M | 63.33% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸32 |  | $8.19 | -1.68% | 446.78M | -10.39% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸33 |  | $8.23 | 0.61% | 405.41M | -6.26% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸34 |  | $2.57 | 3.63% | 388.29M | 19.53% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸35 |  | $5.80 | -2.19% | 358.41M | -10.22% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸36 |  | $8.15 | 0.49% | 355.52M | 20.92% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸37 |  | $2.09 | 7.18% | 351.70M | -34.48% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸38 |  | $10.82 | 1.03% | 333.97M | -27.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸39 |  | $22.05 | -8.13% | 327.80M | 6561.63% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸40 |  | $12.53 | 1.05% | 316.23M | -13.47% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸41 |  | $3.04 | -5.88% | 310.05M | -68.98% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸42 |  | $0.26 | -3.70% | 300.00M | -62.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸43 |  | $6.09 | 2.35% | 298.60M | 185.92% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸44 |  | $7.47 | 1.63% | 267.31M | -31.09% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸45 |  | $8.80 | 1.97% | 254.49M | 490.60% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸46 |  | $11.34 | -0.87% | 250.00M | 173.25% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸47 |  | $11.61 | 0.00% | 243.85M | 1490.41% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸48 |  | $4.90 | 7.69% | 240.29M | 183.24% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸49 |  | $3.22 | 1.26% | 227.87M | -78.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸50 |  | $5.02 | 1.83% | 211.93M | -21.07% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸51 |  | $6.40 | -1.69% | 210.52M | -22.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸52 |  | $3.26 | 0.93% | 202.22M | -65.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸53 |  | $1.62 | 5.88% | 195.34M | -29.26% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸54 |  | $3.87 | -4.68% | 190.72M | -31.02% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸55 |  | $1.94 | 3.74% | 184.07M | -31.21% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇺🇸56 |  | $3.92 | -3.69% | 175.13M | 164.86% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸57 |  | $1.66 | 0.00% | 163.68M | -54.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸58 |  | $12.21 | 0.41% | 156.88M | 15.73% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸59 |  | $0.61 | -0.49% | 154.40M | -68.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸60 |  | $3.02 | 7.47% | 143.67M | -30.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸61 |  | $4.01 | -0.50% | 143.18M | -72.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸62 |  | $21.89 | 0.78% | 142.37M | 200.69% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸63 |  | $3.20 | 13.88% | 132.54M | -59.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸64 |  | $1.03 | 3.00% | 129.06M | 14.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸65 |  | $2.91 | -3.32% | 126.72M | -51.09% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸66 |  | $4.75 | 15.01% | 125.46M | -42.42% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸67 |  | $1.93 | 3.21% | 117.64M | -54.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸68 |  | $2.35 | -6.00% | 115.32M | -63.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸69 |  | $2.19 | 0.00% | 113.08M | -22.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸70 |  | $4.94 | -0.60% | 105.59M | -7.66% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸71 |  | $2.07 | -2.36% | 101.53M | 36.18% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸72 |  | $3.90 | -1.52% | 98.55M | -52.09% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸73 |  | $4.84 | 2.76% | 91.19M | 2488.24% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸74 |  | $1.83 | -2.14% | 91.17M | -87.56% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸75 |  | $4.49 | -1.32% | 80.92M | -59.73% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸76 |  | $2.58 | 0.00% | 80.16M | -33.85% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸77 |  | $1.47 | -2.65% | 75.20M | -52.58% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸78 |  | $2.91 | 0.69% | 74.40M | -32.48% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸79 |  | $1.53 | -8.38% | 73.83M | -21.54% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸80 |  | $3.00 | 4.90% | 73.58M | 47.78% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸81 |  | $1.07 | -1.83% | 71.68M | -32.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸82 |  | $1.60 | -4.19% | 70.92M | -10.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸83 |  | $0.60 | -3.41% | 68.15M | -32.00% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸84 |  | $2.25 | 2.27% | 65.86M | -69.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸85 |  | $1.69 | -3.43% | 65.78M | 94.25% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸86 |  | $1.82 | 5.20% | 60.81M | 112.12% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸87 |  | $5.17 | 0.39% | 58.76M | 176.47% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸88 |  | $1.54 | -1.91% | 55.74M | -60.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸89 |  | $0.95 | 0.00% | 55.40M | -21.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸90 |  | $0.93 | -0.62% | 55.17M | -89.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸91 |  | $0.65 | 6.56% | 51.15M | -17.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸92 |  | $1.64 | -1.80% | 51.02M | -67.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸93 |  | $1.19 | -4.03% | 49.96M | -72.13% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸94 |  | $0.13 | 0.99% | 47.24M | 76.11% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇺🇸95 |  | $1.11 | 0.91% | 47.16M | -84.75% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸96 |  | $1.78 | 5.33% | 46.91M | 2.30% | Underperform S&P500 YTD Benchamark | 🦾 AI | - |
🇺🇸97 |  | $1.01 | -2.88% | 45.57M | -63.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸98 |  | $1.17 | 3.65% | 41.23M | -3.21% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸99 |  | $0.93 | 2.20% | 40.44M | -14.68% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸100 |  | $0.92 | 2.46% | 39.54M | -51.53% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
